Compare McCormick & Company, Incorporated (MKC) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McCormick & Company, Incorporated vs Sana Biotechnology Inc — how do they compare? McCormick & Company, Incorporated trades at $52.01 (market cap $14.04B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: McCormick & Company, Incorporated is far larger — about 16.1× Sana Biotechnology Inc's market cap, and McCormick & Company, Incorporated pays a 3.68% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| MKC | SANA | |
|---|---|---|
Market Cap | $14.04B | $873.84M |
Sector | Consumer Staples | Health |
52-Week High | $72.81 | $5.92 |
52-Week Low | $45.60 | $2.68 |
Enterprise Value | $18.65B | $848.03M |
Dividend Yield | 3.68% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McCormick & Company, Incorporated
In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.
Read more on MKC →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
